Logo image of ADK.CA

DIAGNOS INC (ADK.CA) Stock Fundamental Analysis

TSX-V:ADK - TSX Venture Exchange - CA2524423068 - Common Stock - Currency: CAD

0.25  0 (0%)

Fundamental Rating

0

Taking everything into account, ADK scores 0 out of 10 in our fundamental rating. ADK was compared to 7 industry peers in the Health Care Technology industry. ADK may be in some trouble as it scores bad on both profitability and health. ADK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ADK had negative earnings in the past year.
ADK had a negative operating cash flow in the past year.
In the past 5 years ADK always reported negative net income.
ADK had a negative operating cash flow in each of the past 5 years.
ADK.CA Yearly Net Income VS EBIT VS OCF VS FCFADK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M

1.2 Ratios

The Return On Assets of ADK (-117.56%) is worse than 75.00% of its industry peers.
Industry RankSector Rank
ROA -117.56%
ROE N/A
ROIC N/A
ROA(3y)-313.58%
ROA(5y)-236.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ADK.CA Yearly ROA, ROE, ROICADK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K 20K 30K 40K 50K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ADK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADK.CA Yearly Profit, Operating, Gross MarginsADK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

0

2. Health

2.1 Basic Checks

ADK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ADK has been increased compared to 1 year ago.
The number of shares outstanding for ADK has been increased compared to 5 years ago.
Compared to 1 year ago, ADK has a worse debt to assets ratio.
ADK.CA Yearly Shares OutstandingADK.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ADK.CA Yearly Total Debt VS Total AssetsADK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

Based on the Altman-Z score of -18.25, we must say that ADK is in the distress zone and has some risk of bankruptcy.
ADK has a worse Altman-Z score (-18.25) than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -18.25
ROIC/WACCN/A
WACC9.55%
ADK.CA Yearly LT Debt VS Equity VS FCFADK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

2.3 Liquidity

A Current Ratio of 0.95 indicates that ADK may have some problems paying its short term obligations.
ADK's Current ratio of 0.95 is in line compared to the rest of the industry. ADK outperforms 50.00% of its industry peers.
ADK has a Quick Ratio of 0.95. This is a bad value and indicates that ADK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.95, ADK is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
ADK.CA Yearly Current Assets VS Current LiabilitesADK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

ADK shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.50%.
The Revenue for ADK has decreased by -35.13% in the past year. This is quite bad
Measured over the past years, ADK shows a very negative growth in Revenue. The Revenue has been decreasing by -12.22% on average per year.
EPS 1Y (TTM)-2.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.22%
Revenue 1Y (TTM)-35.13%
Revenue growth 3Y-13.95%
Revenue growth 5Y-12.22%
Sales Q2Q%-50.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.49%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.67%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ADK.CA Yearly Revenue VS EstimatesADK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
ADK.CA Yearly EPS VS EstimatesADK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -0.01 -0.02 -0.03 -0.04 -0.05

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ADK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ADK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADK.CA Price Earnings VS Forward Price EarningsADK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADK.CA Per share dataADK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02 -0.03 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ADK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIAGNOS INC

TSX-V:ADK (5/2/2025, 7:00:00 PM)

0.25

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-26 2025-02-26
Earnings (Next)07-15 2025-07-15
Inst Owners0.01%
Inst Owner ChangeN/A
Ins Owners5.86%
Ins Owner ChangeN/A
Market Cap25.46M
Analysts84.44
Price Target1.53 (512%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-63.64%
Min Revenue beat(2)-64.4%
Max Revenue beat(2)-62.88%
Revenue beat(4)0
Avg Revenue beat(4)-58.83%
Min Revenue beat(4)-64.4%
Max Revenue beat(4)-47.62%
Revenue beat(8)0
Avg Revenue beat(8)-52.78%
Revenue beat(12)1
Avg Revenue beat(12)-43.03%
Revenue beat(16)2
Avg Revenue beat(16)-37.85%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 199.88
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -117.56%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-313.58%
ROA(5y)-236.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.26%
Cap/Sales 10.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z -18.25
F-Score4
WACC9.55%
ROIC/WACCN/A
Cap/Depr(3y)20.66%
Cap/Depr(5y)24.46%
Cap/Sales(3y)6.15%
Cap/Sales(5y)7.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.22%
EPS Next Y-0.49%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.13%
Revenue growth 3Y-13.95%
Revenue growth 5Y-12.22%
Sales Q2Q%-50.12%
Revenue Next Year4.67%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-24.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year66.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-45.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.63%
OCF growth 3YN/A
OCF growth 5YN/A